BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37081700)

  • 1. Clear cell renal cell carcinoma molecular variations in non-Hispanic White and Hispanic patients.
    Batai K; Chen Y; Rheinheimer BA; Arora A; Pandey R; Heimark RL; Bracamonte ER; Ellis NA; Lee BR
    Cancer Med; 2023 Jun; 12(11):12792-12801. PubMed ID: 37081700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/ethnic disparities in renal cell carcinoma: Increased risk of early-onset and variation in histologic subtypes.
    Batai K; Harb-De la Rosa A; Zeng J; Chipollini JJ; Gachupin FC; Lee BR
    Cancer Med; 2019 Nov; 8(15):6780-6788. PubMed ID: 31509346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.
    Haake SM; Brooks SA; Welsh E; Fulp WJ; Chen DT; Dhillon J; Haura E; Sexton W; Spiess PE; Pow-Sang J; Rathmell WK; Fishman M
    Urol Oncol; 2016 Mar; 34(3):122.e1-7. PubMed ID: 26546482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.
    Serie DJ; Joseph RW; Cheville JC; Ho TH; Parasramka M; Hilton T; Thompson RH; Leibovich BC; Parker AS; Eckel-Passow JE
    Eur Urol; 2017 Jun; 71(6):979-985. PubMed ID: 27899233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology.
    Brannon AR; Haake SM; Hacker KE; Pruthi RS; Wallen EM; Nielsen ME; Rathmell WK
    Eur Urol; 2012 Feb; 61(2):258-68. PubMed ID: 22030119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness.
    Eckel-Passow JE; Yan H; Kosel ML; Serie D; Decker PA; Jenkins RB; Costello B; Leibovich B; Ho TH; Parker A
    BMC Urol; 2020 Oct; 20(1):173. PubMed ID: 33121461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma.
    Krishnan B; Rose TL; Kardos J; Milowsky MI; Kim WY
    JAMA Oncol; 2016 May; 2(5):664-667. PubMed ID: 27010573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
    Brooks SA; Brannon AR; Parker JS; Fisher JC; Sen O; Kattan MW; Hakimi AA; Hsieh JJ; Choueiri TK; Tamboli P; Maranchie JK; Hinds P; Miller CR; Nielsen ME; Rathmell WK
    Eur Urol; 2014 Jul; 66(1):77-84. PubMed ID: 24613583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma.
    Purdue MP; Rhee J; Moore L; Gao X; Sun X; Kirk E; Bencko V; Janout V; Mates D; Zaridze D; Petruzella S; Hakimi AA; Linehan WM; Chanock SJ; Brennan P; Furberg H; Troester M; Rothman N
    Int J Cancer; 2021 Oct; 149(7):1448-1454. PubMed ID: 34058014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of clear cell renal cell carcinoma by gene expression profiling.
    Thibodeau BJ; Fulton M; Fortier LE; Geddes TJ; Pruetz BL; Ahmed S; Banes-Berceli A; Zhang PL; Wilson GD; Hafron J
    Urol Oncol; 2016 Apr; 34(4):168.e1-9. PubMed ID: 26670202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial Diversity Among Histology of Renal Cell Carcinoma at an Urban Medical Center.
    Wong KJ; Shusterman M; Goel S; Negassa A; Lin J; Gartrell BA
    Clin Genitourin Cancer; 2021 Jun; 19(3):e166-e170. PubMed ID: 33602582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival.
    Högner A; Krause H; Jandrig B; Kasim M; Fuller TF; Schostak M; Erbersdobler A; Patzak A; Kilic E
    Urol Oncol; 2018 Mar; 36(3):94.e1-94.e14. PubMed ID: 29169846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma].
    Luu VD; Fischer B; von Teichman A; Boysen G; Mertz K; Zimmermann P; Moch H; Schraml P
    Pathologe; 2008 Nov; 29 Suppl 2():303-7. PubMed ID: 18751980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma.
    Xiong Y; Qi Y; Lin W; Bai Q; Liu L; Guo J
    World J Urol; 2021 Apr; 39(4):1203-1210. PubMed ID: 32458095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational status of VHL gene and its clinical importance in renal clear cell carcinoma.
    Alves MR; Carneiro FC; Lavorato-Rocha AM; da Costa WH; da Cunha IW; de Cássio Zequi S; Guimaraes GC; Soares FA; Carraro DM; Rocha RM
    Virchows Arch; 2014 Sep; 465(3):321-30. PubMed ID: 25027579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features.
    Hong B; Cai L; Wang J; Liu S; Zhou J; Ma K; Zhang J; Zhou B; Peng X; Zhang N; Gong K
    Clin Genitourin Cancer; 2019 Apr; 17(2):97-104.e1. PubMed ID: 30522901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas.
    Paulucci DJ; Sfakianos JP; Yadav SS; Badani KK
    Urol Oncol; 2016 Jun; 34(6):259.e9-259.e14. PubMed ID: 26854086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.